Non-endothelial endothelin counteracts hypoxic vasodilation in porcine large coronary arteries

BMC Physiology

Volumn 11, Issue 1, 2011, Pages

  Hedegaard, Elise R ^a   Stankevicius, Edgaras ^b   Simonsen, Ulf ^a   Fröbert, Ole ^a,c  

^a AARHUS UNIVERSITY   (Denmark)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; OXYGEN; POTASSIUM CHANNEL; PROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE;

ANIMAL; ANIMAL MODEL; ANOXIA; ARTICLE; CORONARY BLOOD VESSEL; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SWINE; VASODILATATION;

ANIMALS; ANOXIA; CORONARY VESSELS; DINOPROST; ENDOTHELIN-1; MODELS, ANIMAL; NITRIC OXIDE; OXYGEN; POTASSIUM CHANNELS; REACTIVE OXYGEN SPECIES; SWINE; VASODILATION;

EID: 79955851582     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-11-8     Document Type: Article

References (62)

1. Vasoconstrictor and vasodilator effects of hypoxia. RM Wadsworth, Trends Pharmacol Sci 1994 15 47 53 10.1016/0165-6147(94)90109-0 8165724 (Pubitemid 24053890)
2. Control of coronary blood flow during hypoxemia. JD Tune, Adv Exp Med Biol 2007 618 25 39 10.1007/978-0-387-75434-5-3 18269186
3. Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP. T Graser PM Vanhoutte, Am J Physiol 1991 261 1769 H1777 1661088
4. The ETA antagonist BQ-123 inhibits anoxic contractions of canine coronary arteries without endothelium. YP Vedernikov K Goto PM Vanhoutte, J Cardiovasc Pharmacol 1993 22 Suppl 8 252 S256 7509958 (Pubitemid 24027941)
5. Modification of the ischaemic-induced contraction in the sheep circumflex coronary artery by various pharmacological antagonists. YW Kwan KA Kane, Br J Pharmacol 1990 100 407 412 2390668 (Pubitemid 20222265)
6. Two distinct effects of oxygen on vascular tone in isolated porcine coronary arteries. GM Rubanyi RJ Paul, Circ Res 1985 56 1 10 2981644 (Pubitemid 15130235)
7. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. H Rakugi Y Tabuchi M Nakamaru M Nagano K Higashimori H Mikami T Ogihara N Suzuki, Biochem Biophys Res Commun 1990 169 973 977 10.1016/0006-291X(90)91989-6 2194458 (Pubitemid 20220715)
8. Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. HS Hieda CE Gomez-Sanchez, Life Sci 1990 47 247 251 10.1016/0024-3205(90)90327-N 2201863 (Pubitemid 20243805)
9. Selective and mixed endothelin receptor antagonism in cardiovascular disease. N Dhaun DM Pollock J Goddard DJ Webb, Trends Pharmacol Sci 2007 28 573 579 10.1016/j.tips.2007.10.002 17950470 (Pubitemid 350026612)
10. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. N Duerrschmidt N Wippich W Goettsch HJ Broemme H Morawietz, Biochem Biophys Res Commun 2000 269 713 717 10.1006/bbrc.2000.2354 10720482 (Pubitemid 30440367)
11. Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall, and intimal hyperplasia in perimenopausal human uterine arteries. M Beppu S Obayashi T Aso M Goto H Azuma, J Cardiovasc Pharmacol 2002 39 192 200 10.1097/00005344-200202000-00005 11791004 (Pubitemid 34093538)
12. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure. M Ohnishi A Wada T Tsutamoto M Fujii T Matsumoto T Yamamoto T Takayama X Wang M Kinoshita, Clin Sci (Lond) 2002 103 Suppl 48 241S 244S (Pubitemid 35007161)
13. Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization. O Frøbert SP Hjortshoj U Simonsen J Ravkilde, Int J Cardiol 2007 129 288 291 17689741
14. Enalapril attenuates endothelin-1-induced hypertension via increased kinin survival. AA Elmarakby P Morsing DM Pollock, Am J Physiol Heart Circ Physiol 2003 284 1899 H1903 12574005 (Pubitemid 36622397)
15. The effect of tempol on endothelium-dependent vasodilatation and blood pressure. U Simonsen FH Christensen NH Buus, Pharmacol Ther 2009 122 109 124 10.1016/j.pharmthera.2009.02.002 19268689
16. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. JS Beckman WH Koppenol, Am J Physiol 1996 271 1424 C1437 8944624
17. A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. T Bjornheden M Evaldsson O Wiklund, Arterioscler Thromb Vasc Biol 1996 16 178 185 8548420 (Pubitemid 26026949)
18. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. 2010 http://conventions.coe.int/ Treaty/en/Treaties/html/123.htm Ref Type: Online Source
19. Hyperoxia reduces basal release of nitric oxide and contracts porcine coronary arteries. T Pasgaard E Stankevicius MM Jorgensen L Ostergaard U Simonsen O Frøbert, Acta Physiol (Oxf) 2007 191 285 296 10.1111/j.1748-1716.2007.01745.x (Pubitemid 350077448)
20. The active tension-length curve of vascular smooth muscle related to its cellular components. MJ Mulvany DM Warshaw, J Gen Physiol 1979 74 85 104 10.1085/jgp.74.1.85 479823 (Pubitemid 9220542)
21. Blunted acetylcholine relaxation and nitric oxide release in arteries from renal hypertensive rats. E Stankevicius AC Martinez MJ Mulvany U Simonsen, J Hypertens 2002 20 1571 1579 10.1097/00004872-200208000-00020 12172319 (Pubitemid 34921181)
22. The influence of transmural pressure and longitudinal stretch on K+- and Ca2+-induced coronary artery constriction. O Frøbert EO Mikkelsen JP Bagger, Acta Physiol Scand 1999 165 379 385 10.1046/j.1365-201x.1999.00519.x 10350232 (Pubitemid 29224644)
23. Measurement of interstitial lactate during hypoxia-induced dilatation in isolated pressurised porcine coronary arteries. O Frøbert EO Mikkelsen JP Bagger CH Gravholt, J Physiol 2002 539 277 284 10.1113/jphysiol.2001.013180 11850519 (Pubitemid 35190114)
24. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. RH Boger SM Bode-Boger A Szuba PS Tsao JR Chan O Tangphao TF Blaschke JP Cooke, Circulation 1998 98 1842 1847 9799202 (Pubitemid 28509278)
25. Blunted non-nitric oxide vasodilatory neurotransmission in penile arteries from renal hypertensive rats. AC Martinez E Stankevicius P Jakobsen U Simonsen, Vascul Pharmacol 2006 44 354 362 10.1016/j.vph.2006.01.014 16574496
26. Endothelin production by hypoxic human endothelium. JP Gertler VH Ocasio, J Vasc Surg 1993 18 178 182 10.1067/mva.1993.41959 8350426
27. Endothelin production in cultured vascular smooth muscle cells - modulation by the atrial, brain, and C-type natriuretic peptide system. T Hanehira M Kohno J Yoshikawa, Metabolism 1997 46 487 493 10.1016/S0026-0495(97) 90182-7 9160812 (Pubitemid 27214869)
28. Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. NJ Davie EV Gerasimovskaya SE Hofmeister AP Richman PL Jones JT Reeves KR Stenmark, Am J Pathol 2006 168 1793 1807 10.2353/ajpath.2006.050754 16723696 (Pubitemid 43825301)
29. Evidence for receptor bound endothelin in renal but not in cardiac tissues from normal rats. E Ferrari A Talbodec P Vigne C Frelin, Cardiovasc Res 1998 38 140 148 10.1016/S0008-6363(97)00320-9 9683916 (Pubitemid 28275624)
30. L-nitro-arginine inhibits increase in endothelin binding sites induced by ischemia and reperfusion. T Saito E Fushimi T Tamura Y Fujiwara H Miura H Watanabe S Kibira H Hasegawa M Miura, J Mol Cell Cardiol 2002 34 1041 1047 10.1006/jmcc.2002.2044 12234773 (Pubitemid 35316151)
31. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist. EH Ohlstein P Nambi A Lago DW Hay G Beck KL Fong EP Eddy P Smith H Ellens JD Elliott, J Pharmacol Exp Ther 1996 276 609 615 8632328 (Pubitemid 126660499)
32. Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction. D Merkus B Houweling AH van Den Meiracker F Boomsma DJ Duncker, Am J Physiol Heart Circ Physiol 2005 288 871 H880 15458948 (Pubitemid 40139674)
33. Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids. B Climent N Fernandez E Sanz A Sanchez L Monge AL Garcia-Villalon G Dieguez, Eur J Pharmacol 2005 524 102 110 10.1016/j.ejphar.2005.09.002 16243311 (Pubitemid 41606821)
34. Effects of oxygen tension on flow-induced vasodilation in porcine coronary resistance arterioles. AH Jimenez MA Tanner WM Caldwell PR Myers, Microvasc Res 1996 51 365 377 10.1006/mvre.1996.0033 8992234 (Pubitemid 26162002)
35. Does nitric oxide allow endothelial cells to sense hypoxia and mediate hypoxic vasodilatation? In vivo and in vitro studies. NJ Edmunds S Moncada JM Marshall, J Physiol 2003 546 521 527 10.1113/jphysiol.2002.023663 12527738 (Pubitemid 36175987)
36. Inhibition of hypoxia-induced relaxation of rabbit isolated coronary arteries by NG-monomethyl-L-arginine but not glibenclamide. C Jiang P Collins, Br J Pharmacol 1994 111 711 716 8019749 (Pubitemid 24151654)
37. Role of nitric oxide in hypoxic coronary vasodilatation in isolated perfused guinea pig heart. IP Brown CI Thompson FL Belloni, Am J Physiol 1993 264 821 H829 8456983 (Pubitemid 23109874)
38. Role of myocardium and endothelium in coronary vascular smooth muscle responses to hypoxia. CJ Kerkhof PJ Van Der Linden P Sipkema, Am J Physiol Heart Circ Physiol 2002 282 1296 H1303 11893564 (Pubitemid 34654881)
39. Reduced perivascular PO2 increases nitric oxide release from endothelial cells. GP Nase J Tuttle HG Bohlen, Am J Physiol Heart Circ Physiol 2003 285 507 H515 12860561 (Pubitemid 36885880)
40. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. SL Archer JM Huang V Hampl DP Nelson PJ Shultz EK Weir, Proc Natl Acad Sci USA 1994 91 7583 7587 10.1073/pnas.91.16.7583 7519783 (Pubitemid 24238229)
41. Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries. CJ Mingone SA Gupte T Iesaki MS Wolin, Am J Physiol Lung Cell Mol Physiol 2003 285 296 L304 12691956 (Pubitemid 36909445)
42. Say NO to ET. PM Vanhoutte, J Auton Nerv Syst 2000 81 271 277 10.1016/S0165-1838(00)00126-0 10869731 (Pubitemid 30408509)
43. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. C Boulanger TF Luscher, J Clin Invest 1990 85 587 590 10.1172/JCI114477 2153712 (Pubitemid 20070070)
44. Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Y Miyoshi Y Nakaya T Wakatsuki S Nakaya K Fujino K Saito I Inoue, Circ Res 1992 70 612 616 1537097
45. Dual action of endothelin-1 on the Ca2(+)-activated K+ channel in smooth muscle cells of porcine coronary artery. SL Hu HS Kim AY Jeng, Eur J Pharmacol 1991 194 31 36 10.1016/0014-2999(91)90120-F 1647962
46. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. S Saitoh C Zhang JD Tune B Potter T Kiyooka PA Rogers JD Knudson GM Dick A Swafford WM Chilian, Arterioscler Thromb Vasc Biol 2006 26 2614 2621 10.1161/01.ATV.0000249408.55796.da 17023676
47. Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury. GB Bhat SB Tinsley JK Tolson JM Patel ER Block, J Cell Physiol 1992 151 228 238 10.1002/jcp.1041510203 1572899
48. Hypoxia increases superoxide anion production from bovine coronary microvessels, but not cardiac myocytes, via increased xanthine oxidase. PM Kaminski MS Wolin, Microcirculation 1994 1 231 236 10.3109/10739689409146750 8790592
49. Hypoxia stimulates release of endothelium-derived relaxant factor. U Pohl R Busse, Am J Physiol 1989 256 1595 H1600 2660596
50. Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function. AJ Thomson GB Drummond WS Waring DJ Webb SR Maxwell, J Appl Physiol 2006 101 809 816 10.1152/japplphysiol.01185.2005 16902069 (Pubitemid 44352294)
51. Hypoxia sensing in the fetal chicken femoral artery is mediated by the mitochondrial electron transport chain. B Zoer AL Cogolludo F Perez-Vizcaino JG De Mey CE Blanco E Villamor, Am J Physiol Regul Integr Comp Physiol 2010 298 1026 R1034 10.1152/ajpregu.00500.2009 20089711
52. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. S Heumuller S Wind E Barbosa-Sicard HH Schmidt R Busse K Schroder RP Brandes, Hypertension 2008 51 211 217 10.1161/HYPERTENSIONAHA.107.100214 18086956 (Pubitemid 351159930)
53. Contributory role of endothelium and voltage-gated potassium channels in apocynin-induced vasorelaxations. WQ Han WT Wong XY Tian Y Huang LY Wu DL Zhu PJ Gao, J Hypertens 2010 28 2102 2110 20706137
54. Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation. U Simonsen R Rodriguez-Rodriguez T Dalsgaard NH Buus E Stankevicius, Pharmacol Rep 2009 61 105 115 19307698
55. Reactive oxygen species and the control of vascular function. MS Wolin, Am J Physiol Heart Circ Physiol 2009 296 539 H549 10.1152/ajpheart.01167.2008 19151250
56. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. CT Taylor S Moncada, Arterioscler Thromb Vasc Biol 2010 30 643 647 10.1161/ATVBAHA.108.181628 19713530
57. Mitochondrial-derived hydrogen peroxide inhibits relaxation of bovine coronary arterial smooth muscle to hypoxia through stimulation of ERK MAP kinase. Q Gao X Zhao M Ahmad MS Wolin, Am J Physiol Heart Circ Physiol 2009 297 2262 H2269 10.1152/ajpheart.00817.2009 19855056
58. Energetic effects of adenosine on vascular smooth muscle. JT Barron L Gu, Am J Physiol Heart Circ Physiol 2000 278 26 H32 10644580 (Pubitemid 30101852)
59. Effects of hypoxia on isometric force, intracellular Ca(2+), pH, and energetics in porcine coronary artery. S Shimizu PS Bowman G Thorne RJ Paul, Circ Res 2000 86 862 870 10785508 (Pubitemid 30246983)
60. Influence of oxygen tension on myocardial performance. Evaluation by tissue Doppler imaging. O Frøbert J Moesgaard E Toft SH Poulsen P Sogaard, Cardiovasc Ultrasound 2004 2 22 30 10.1186/1476-7120-2-22 15522119
61. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. PL Ludmer AP Selwyn TL Shook RR Wayne GH Mudge RW Alexander P Ganz, N Engl J Med 1986 315 1046 1051 10.1056/NEJM198610233151702 3093861 (Pubitemid 17170620)
62. Acute endothelin(A) receptor antagonism improves coronary artery compliance in coronary artery disease patients. ZS Kyriakides DT Kremastinos F Kolokathis A Kostopoulou M Georgiadis DJ Webb, Clin Sci (Lond) 2002 103 Suppl 48 179S 183S (Pubitemid 35007147)